MASCO

SECTION 2: Hazards identification

Emergency Overview Clear. Liquid. May cause moderate irritation to the respiratory system. May cause nausea, headaches, and dizziness. May cause drowsiness, weakness, and fatigue. Move to fresh air. If required, artificial respiration or administration of oxygen can be performed by trained personnel. Leave area to breathe fresh air. Avoid further overexposure. If symptoms persist, get medical attention. Acute Potential Health Effects/ Routes of Entry Inhalation May cause moderate irritation to the respiratory system. May cause nausea, headaches, and dizziness. May cause drowsiness, weakness, and fatigue. Eyes Vapor and/or mist may cause eye irritation. Direct contact may cause temporary redness and discomfort. Ingestion May cause irritation to the mouth, throat and stomach. May cause gastrointestinal irritation, nausea, and vomiting. Skin May cause moderate irritation.

Medical Conditions Generally Aggravated by Exposure

Pre-existing eye, skin, liver, kidney, and respiratory disorders may be aggravated by exposure.

Potential chronic health

Reports have associated repeated and prolonged occupational overexposure to solvents with permanent brain and nervous system damage. Intentional misuse by deliberately concentrating and inhaling contents may be harmful or fatal. Prolonged or repeated exposure to xylene may cause defatting, drying, and irritation of the skin, dermatitis, central nervous system (CNS) effects, heart muscle sensitization and arrhythmia, hearing loss, and brain, liver, kidney damage. Xylene overexposure may affect fetal development. Prolonged or repeated contact/exposure to aromatic petroleum distillates may cause defatting, drying, and irritation of the skin, dermatitis, and central nervous system (CNS) effects. The International Agency for Research on Cancer (IARC) has evaluated ethylbenzene and classified it as a possible human carcinogen (Group 2B) based on sufficient evidence for carcinogenicity in experimental animals, but inadequate evidence for cancer in exposed humans. Fillers are encapsulated and not expected to be released from product under normal conditions of use. Target Organs: Skin, Eye, Lung, Liver, Kidney, Nerve, Reproductive 1 Revision Date: 10/27/2014 SECTION 3 - PRODUCT COMPOSITION Chemical Name CAS-No. Weight % Aromatic petroleum distillates 64742-95-6 30.0 - 60.0 1,2,4-Trimethylbenzene 95-63-6 15.0 - 40.0 Styrene Ethylhexyl Acrylate NJ TSRN# 51721300-5841P 15.0 - 40.0 Copolymer 1,3,5-Trimethylbenzene 108-67-8 3.0 - 7.0 Xylene 1330-20-7 1.0 - 5.0 Cumene 98-82-8 1.0 - 5.0 Bis (2-propylheptyl) phthalate 53306-54-0 1.0 - 5.0 Ethylbenzene 100-41-4 0.1 - 1.0